Stocks/TSX/MRK

Merck CDR (CAD Hedged) (MRK : TSX)

Common Stock

$27.02

CAD

+0.52 (1.96%)

Last updated: 2026-06-24

MRK

Merck CDR (CAD Hedged)

Source:WealthAwesomeWealthAwesome
$1.45 (5.67%)
30 day period
$25.02$26.21$27.40May 13Jun 4Jun 24

Performance

1 Day

+1.96%

1 Week

+4.81%

1 Month

-1.10%

YTD

+12.49%

Key Statistics

Market Cap

$296.29B

52W High

$27.91

52W Low

$17.11

P/E Ratio

33.40

50 Day MA

$25.90

200 Day MA

$26.10

Beta

-

Dividend Yield

12.27%

Technical Indicators

Price vs 50-Day SMA

Above 50 SMA

Price vs 200-Day SMA

Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
6/24/2026$27.05$27.05$26.87$27.02$27.022,814
6/23/2026$26.45$26.50$26.45$26.50$26.505,272
6/22/2026$25.73$25.84$25.73$25.84$25.84454
6/19/2026$25.55$25.68$25.55$25.68$25.68473
6/18/2026$25.81$25.81$25.00$25.49$25.494,620
6/17/2026$25.78$25.78$25.78$25.78$25.78208
6/16/2026$25.73$25.73$25.73$25.73$25.730
6/15/2026$25.81$26.00$25.80$25.80$25.803,029
6/12/2026$27.15$27.15$26.63$26.63$26.634,427
6/11/2026$27.13$27.44$27.07$27.07$27.072,994

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on MRK's historical volatility

HistoricalForecast68%95%
C$18.26C$23.08C$27.89C$32.71C$37.53C$42.35TodayFeb 13Apr 22Jun 24Aug 6Sep 19Nov 1

30-Day Vol

32.7%

Annualized

90-Day Vol

27.7%

Annualized

Trend (90d)

+8.2%

Annualized drift

90d Mean

C$27.82

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$27.28C$24.37C$30.54
60 trading daysC$27.55C$23.49C$32.31
90 trading daysC$27.82C$22.88C$33.82

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Merck CDR (CAD Hedged)

Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. It has a collaboration agreement with Antengene Corporation Limited to evaluate the combination of ATG-022, a CLDN18.2-targeting antibody-drug conjugate, and anti-PD-1 therapy, as well as KEYTRUDA (pembrolizumab) in patients with advanced solid tumors. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.

Financials

Revenue (TTM)
$0
EBITDA
-
Profit Margin
0.00%
ROE (TTM)
3690.70%
EPS (Diluted)
0.00
Book Value
-

💰 Recent Dividends

$0.1915

Ex: Dec 15, 2025

$0.1848

Ex: Sep 15, 2025

$0.1851

Ex: Jun 16, 2025

$0.1837

Ex: Mar 17, 2025

Advertisement

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Common Questions About MRK

Advertisement